In this population-level cohort study of 20 low-mortality countries, females aged 35 to 60 years experienced disadvantage in cancer mortality compared with males-a consistent pattern observed across birth cohorts and over time. These findings underscore the ongoing need for action on the prevention, early detection, and treatment of early-onset female reproductive cancers.
Canudas-Romo et al. (Tue,) studied this question.